#sclerodermaforum 검색 결과
🔎 Discover the newest findings in #scleroderma in our latest literature highlights. Enhance your clinical knowledge with free access on the #SclerodermaForum: ow.ly/1URA50WYO7G
The ReSScue trial provides valuable insights that can inform future GIT studies in patients with systemic sclerosis, as shown by Fretheim et al. 👀See the full insights from the #SclerodermaForum: ow.ly/hm7A50WnvS8
⭐ Enhance your understanding of #scleroderma with our newly uploaded slide deck and literature highlights. Visit the #SclerodermaForum today to access these free resources: ow.ly/KfY150WYO5E
👀Looking for the latest insights in #scleroderma? Our new slide deck and literature highlights are live on the #SclerodermaForum. 🔗Access these valuable resources today: ow.ly/wW5E50WYNWR
📣 Stay informed with our latest #scleroderma literature highlights and detailed slide decks. Now available for free on the #SclerodermaForum: ow.ly/LWs150WYO4Z
👉 #SclerodermaForum is featured in The Scleroderma Research Foundation (#SRF) July eNewsletter. Read the newsletter here 🔗ow.ly/nzT550Wu2Za
The Scleroderma Research Foundation (#SRF) featured #SclerodermaForum in its July eNewsletter. 🗞️ Access the newsletter today. 🔗ow.ly/lUx450Wu36Y
🔎Discover the newest findings in #Scleroderma in our latest literature highlights. Enhance your clinical knowledge with free access on the #SclerodermaForum: ow.ly/tPqL50Wnw2Z
Enhance your understanding of #Scleroderma with our newly uploaded slide decks and literature highlights. 👉Visit the #SclerodermaForum today to access these free resources: ow.ly/tlCj50Wnw0U
📰Our latest #Scleroderma literature highlights, featuring research by Denton, et al. are now live on the #SclerodermaForum. Access these comprehensive slide decks for the latest insights in Scleroderma treatment: ow.ly/VlA750WnvWE
Denton et al. reported weekly high-dose IgPro20 and monthly IgPro10 to be well-tolerated in patients with dcSSc. 👉Find out more from this paper over on the #SclerodermaForum. ow.ly/YWLI50WnvLa
In patients with dcSSc, safety, PK and bioavailability profiles of IgPro20, and safety and PK of IgPro10, are similar to those observed in other approved indications, as shown by Denton et al. 👀See the full insights from the #SclerodermaForum: ow.ly/Fbxf50WnvRm
In systemic sclerosis patients, Fretheim et al. observed that the safety profile of faecal microbiota transplantation with ACHIM was comparable to that of placebo. 👀Learn more here: ow.ly/SOLt50WnvOh #SclerodermaForum
Denton et al. report that weekly SC immunoglobulin and monthly IV immunoglobulin were well-tolerated in patients with systemic sclerosis. No new safety concerns were observed. 👇👇 ow.ly/3IW450WnvNI #SclerodermaForum
Fretheim et al. reported faecal microbiota transplantation with ACHIM was well-tolerated in participants with systemic sclerosis but did not result in an improvement in lower gastrointestinal tract symptoms. 📑Find out more on the #SclerodermaForum. ow.ly/gahg50WnvJy
This target trial emulation used real-world data from 208 matched patients with early dcSSc. Both treatment strategies—immunosuppression alone or with GCs—led to similar skin score improvements. 👀See full insights from Mongin et al. #SclerodermaForum scleroderma-forum.com/literature-rev…
Fretheim et al. report that 48% of systemic sclerosis patients receiving faecal microbiota transplantation with ACHIM experienced adverse events, mostly mild and short-lived gastrointestinal tract symptoms. 👂Learn more on the #SclerodermaForum: ow.ly/UgEY50WnvMY
After the successful launch of #SclerodermaForum at this year’s #EULAR, The Scleroderma Research Foundation (#SRF) has featured us in their July eNewsletter. 📧 Access the newsletter 🔗ow.ly/NliR50Wu3cG
🌟Following last month’s launch at #EULAR, #SclerodermaForum is featured in the July eNewsletter from The Scleroderma Research Foundation (#SRF). Visit the newsletter today 🔗ow.ly/lS6T50Wu2Ug
🔎 Discover the newest findings in #scleroderma in our latest literature highlights. Enhance your clinical knowledge with free access on the #SclerodermaForum: ow.ly/1URA50WYO7G
⭐ Enhance your understanding of #scleroderma with our newly uploaded slide deck and literature highlights. Visit the #SclerodermaForum today to access these free resources: ow.ly/KfY150WYO5E
📣 Stay informed with our latest #scleroderma literature highlights and detailed slide decks. Now available for free on the #SclerodermaForum: ow.ly/LWs150WYO4Z
👀Looking for the latest insights in #scleroderma? Our new slide deck and literature highlights are live on the #SclerodermaForum. 🔗Access these valuable resources today: ow.ly/wW5E50WYNWR
The ReSScue trial provides valuable insights that can inform future GIT studies in patients with systemic sclerosis, as shown by Fretheim et al. 👀See the full insights from the #SclerodermaForum: ow.ly/hm7A50WnvS8
In patients with dcSSc, safety, PK and bioavailability profiles of IgPro20, and safety and PK of IgPro10, are similar to those observed in other approved indications, as shown by Denton et al. 👀See the full insights from the #SclerodermaForum: ow.ly/Fbxf50WnvRm
Enhance your understanding of #Scleroderma with our newly uploaded slide decks and literature highlights. 👉Visit the #SclerodermaForum today to access these free resources: ow.ly/tlCj50Wnw0U
This target trial emulation used real-world data from 208 matched patients with early dcSSc. Both treatment strategies—immunosuppression alone or with GCs—led to similar skin score improvements. 👀See full insights from Mongin et al. #SclerodermaForum scleroderma-forum.com/literature-rev…
After the successful launch of #SclerodermaForum at this year’s #EULAR, The Scleroderma Research Foundation (#SRF) has featured us in their July eNewsletter. 📧 Access the newsletter 🔗ow.ly/NliR50Wu3cG
📰Our latest #Scleroderma literature highlights, featuring research by Denton, et al. are now live on the #SclerodermaForum. Access these comprehensive slide decks for the latest insights in Scleroderma treatment: ow.ly/VlA750WnvWE
The Scleroderma Research Foundation (#SRF) featured #SclerodermaForum in its July eNewsletter. 🗞️ Access the newsletter today. 🔗ow.ly/lUx450Wu36Y
👉 #SclerodermaForum is featured in The Scleroderma Research Foundation (#SRF) July eNewsletter. Read the newsletter here 🔗ow.ly/nzT550Wu2Za
🔔Stay informed with our latest #Scleroderma literature highlights and detailed slide decks. Now available for free on the #SclerodermaForum: ow.ly/ufVP50WnvZk
In systemic sclerosis patients, Fretheim et al. observed that the safety profile of faecal microbiota transplantation with ACHIM was comparable to that of placebo. 👀Learn more here: ow.ly/SOLt50WnvOh #SclerodermaForum
Denton et al. report that weekly SC immunoglobulin and monthly IV immunoglobulin were well-tolerated in patients with systemic sclerosis. No new safety concerns were observed. 👇👇 ow.ly/3IW450WnvNI #SclerodermaForum
Fretheim et al. report that 48% of systemic sclerosis patients receiving faecal microbiota transplantation with ACHIM experienced adverse events, mostly mild and short-lived gastrointestinal tract symptoms. 👂Learn more on the #SclerodermaForum: ow.ly/UgEY50WnvMY
🌟Following last month’s launch at #EULAR, #SclerodermaForum is featured in the July eNewsletter from The Scleroderma Research Foundation (#SRF). Visit the newsletter today 🔗ow.ly/lS6T50Wu2Ug
🔎Discover the newest findings in #Scleroderma in our latest literature highlights. Enhance your clinical knowledge with free access on the #SclerodermaForum: ow.ly/tPqL50Wnw2Z
💡Enhance your understanding of #Scleroderma with our newly uploaded slide decks and literature highlights. Visit the #SclerodermaForum today to access these free resources: ow.ly/q0fn50Wnuhz
👀Looking for the latest insights in #Scleroderma? Our new slide decks and literature highlights are live on the #SclerodermaForum. Access these valuable resources today: ow.ly/KVsX50WnvX9
Something went wrong.
Something went wrong.
United States Trends
- 1. D’Angelo 197K posts
- 2. D'Angelo 196K posts
- 3. Brown Sugar 16.3K posts
- 4. Black Messiah 7,755 posts
- 5. Voodoo 16K posts
- 6. #PortfolioDay 10.3K posts
- 7. Happy Birthday Charlie 122K posts
- 8. Powell 38.2K posts
- 9. How Does It Feel 7,347 posts
- 10. Young Republicans 4,557 posts
- 11. Pentagon 99.2K posts
- 12. Osimhen 130K posts
- 13. Alex Jones 28.4K posts
- 14. #BornOfStarlightHeeseung 82.4K posts
- 15. Neo-Soul 18.3K posts
- 16. Sandy Hook 11.4K posts
- 17. CJGJ N/A
- 18. VPNs 1,083 posts
- 19. Untitled 6,442 posts
- 20. Baldwin 17.1K posts